Brief: Hofseth Biocare Q2 Revenue NOK 68.4 Million
22/08/2025 07:00
Aug 22 (Reuters) - Hofseth Biocare Q2 EBITDA NOK -5.4 million.
Recent news on Hofseth Biocare ASA
See all newsBrief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering